Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	May 31, 2024	May 31, 2023
Cash flows from operating activities
Net loss	$ (3,929,520)	$ (4,390,863)
Adjustments for non-cash income and expenses:
Depreciation	187,729	126,139
Amortization	3,118,041	3,118,041
Property, plant and equipment impairment and abandonments		21,387
Changes in operating assets and liabilities:
(Increase)/decrease in accounts receivables	(12,647)	11,928
(Increase)/decrease in inventories	(104,992)	25,532
Decrease in deposit, prepayments and advances to suppliers	147,654	205,213
Decrease in operating lease right-of-use assets	61,351	148,286
Increase/(decrease) in accounts payable and accruals	56,584	(74,641)
Decrease in deferred revenue	(48,632)	(69,922)
Decrease in operating lease liabilities	(64,369)	(165,987)
Decrease in other payables	(6,258)	(14,152)
Increase in amounts due to shareholders	524,587	303,123
Net cash used in operations	(70,472)	(755,916)
Cash flows from investing activity
Purchase of property, plant and equipment	(102,414)	(29,473)
Cash used in investing activity	(102,414)	(29,473)
Cash flows from financing activities
Payments of hire purchase	(5,885)	(6,570)
Payment of offering costs	(449,576)
Proceeds from issuance of common stock		443,498
Proceeds from shares to be issued		625,331
Proceeds from capital contribution	65,598	157,255
Net cash (used in)/generated from financing activities	(389,863)	1,219,514
Net (decrease)/increase in cash and cash equivalents	(562,749)	434,125
Effect of exchange rate changes	(170,798)	(61,568)
Cash and cash equivalents at start of period	779,049	152,304
Cash and cash equivalents at end of period	$ 45,502	$ 524,861